Skip to main content
Premium Trial:

Request an Annual Quote

Joslin Diabetes Center to Use Metabolon Profiling Technology in Studies

NEW YORK (GenomeWeb News) – The Joslin Diabetes Center will use Metabolon’s biochemical profiling technology in human clinical and animal studies of insulin resistance and type 2 diabetes, Metabolon said today.
Research Triangle Park, NC-based Metabolon also will assess the translatability of its human insulin resistance biomarkers when conducting the Joslin diabetic animal model studies. In addition, the partners will collaborate on further validation studies of human biochemical markers of insulin resistance.
Metabolon noted that it is working with academic centers around the world on developing a diagnostic test for insulin resistance, a condition which the firm said affects more than a quarter of the US adult population.
“Mechanism-based biomarker diagnostics are a much-needed tool in the identification and management of patients at risk for type 2 diabetes and cardiovascular disease," Metabolon CEO John Ryals said in a statement. "Our partnership with Joslin gives us the opportunity to further validate the biomarkers of insulin resistance that we have identified."
Financial and other terms of the collaboration were not disclosed.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.